Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Differential Innate Immune Responses Elicited by Nipah Virus and Cedar Virus Correlate with Disparate In Vivo Pathogenesis in Hamsters.

Schountz T, Campbell C, Wagner K, Rovnak J, Martellaro C, DeBuysscher BL, Feldmann H, Prescott J.

Viruses. 2019 Mar 22;11(3). pii: E291. doi: 10.3390/v11030291.

2.

Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo.

Garrido JL, Prescott J, Calvo M, Bravo F, Alvarez R, Salas A, Riquelme R, Rioseco ML, Williamson BN, Haddock E, Feldmann H, Barria MI.

Sci Transl Med. 2018 Nov 21;10(468). pii: eaat6420. doi: 10.1126/scitranslmed.aat6420. Erratum in: Sci Transl Med. 2019 Jan 16;11(475):.

PMID:
30463919
3.

Pathogenicity of Ebola and Marburg Viruses Is Associated With Differential Activation of the Myeloid Compartment in Humanized Triple Knockout-Bone Marrow, Liver, and Thymus Mice.

Lavender KJ, Williamson BN, Saturday G, Martellaro C, Griffin A, Hasenkrug KJ, Feldmann H, Prescott J.

J Infect Dis. 2018 Nov 22;218(suppl_5):S409-S417. doi: 10.1093/infdis/jiy269.

PMID:
30085162
4.

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques.

Prescott J, Falzarano D, de Wit E, Hardcastle K, Feldmann F, Haddock E, Scott D, Feldmann H, Munster VJ.

Front Immunol. 2018 Feb 12;9:205. doi: 10.3389/fimmu.2018.00205. eCollection 2018.

5.

Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver.

Spengler JR, Saturday G, Lavender KJ, Martellaro C, Keck JG, Nichol ST, Spiropoulou CF, Feldmann H, Prescott J.

J Infect Dis. 2017 Dec 27;217(1):58-63. doi: 10.1093/infdis/jix562.

6.

Human immune system mouse models of Ebola virus infection.

Spengler JR, Prescott J, Feldmann H, Spiropoulou CF.

Curr Opin Virol. 2017 Aug;25:90-96. doi: 10.1016/j.coviro.2017.07.028. Epub 2017 Aug 12. Review.

7.

Immunobiology of Ebola and Lassa virus infections.

Prescott JB, Marzi A, Safronetz D, Robertson SJ, Feldmann H, Best SM.

Nat Rev Immunol. 2017 Mar;17(3):195-207. doi: 10.1038/nri.2016.138. Epub 2017 Jan 23. Review.

PMID:
28111475
8.

Amending Koch's postulates for viral disease: When "growth in pure culture" leads to a loss of virulence.

Prescott J, Feldmann H, Safronetz D.

Antiviral Res. 2017 Jan;137:1-5. doi: 10.1016/j.antiviral.2016.11.002. Epub 2016 Nov 8. Review.

9.

Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment.

Spengler JR, Lavender KJ, Martellaro C, Carmody A, Kurth A, Keck JG, Saturday G, Scott DP, Nichol ST, Hasenkrug KJ, Spiropoulou CF, Feldmann H, Prescott J.

J Infect Dis. 2016 Oct 15;214(suppl 3):S308-S318. Epub 2016 Sep 6. Erratum in: J Infect Dis. 2017 Nov 15;216(8):1048.

10.

Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients.

Rosenke K, Adjemian J, Munster VJ, Marzi A, Falzarano D, Onyango CO, Ochieng M, Juma B, Fischer RJ, Prescott JB, Safronetz D, Omballa V, Owuor C, Hoenen T, Groseth A, Martellaro C, van Doremalen N, Zemtsova G, Self J, Bushmaker T, McNally K, Rowe T, Emery SL, Feldmann F, Williamson BN, Best SM, Nyenswah TG, Grolla A, Strong JE, Kobinger G, Bolay FK, Zoon KC, Stassijns J, Giuliani R, de Smet M, Nichol ST, Fields B, Sprecher A, Massaquoi M, Feldmann H, de Wit E.

Clin Infect Dis. 2016 Oct 15;63(8):1026-33. doi: 10.1093/cid/ciw452. Epub 2016 Aug 15.

11.

Clinical Chemistry of Patients With Ebola in Monrovia, Liberia.

de Wit E, Kramer S, Prescott J, Rosenke K, Falzarano D, Marzi A, Fischer RJ, Safronetz D, Hoenen T, Groseth A, van Doremalen N, Bushmaker T, McNally KL, Feldmann F, Williamson BN, Best SM, Ebihara H, Damiani IA, Adamson B, Zoon KC, Nyenswah TG, Bolay FK, Massaquoi M, Sprecher A, Feldmann H, Munster VJ.

J Infect Dis. 2016 Oct 15;214(suppl 3):S303-S307. Epub 2016 Jul 28.

12.

Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015.

de Wit E, Rosenke K, Fischer RJ, Marzi A, Prescott J, Bushmaker T, van Doremalen N, Emery SL, Falzarano D, Feldmann F, Groseth A, Hoenen T, Juma B, McNally KL, Ochieng M, Omballa V, Onyango CO, Owuor C, Rowe T, Safronetz D, Self J, Williamson BN, Zemtsova G, Grolla A, Kobinger G, Rayfield M, Ströher U, Strong JE, Best SM, Ebihara H, Zoon KC, Nichol ST, Nyenswah TG, Bolay FK, Massaquoi M, Feldmann H, Fields B.

J Infect Dis. 2016 Oct 15;214(suppl 3):S169-S176. Epub 2016 Jun 21.

13.

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak.

de Wit E, Falzarano D, Onyango C, Rosenke K, Marzi A, Ochieng M, Juma B, Fischer RJ, Prescott JB, Safronetz D, Omballa V, Owuor C, Hoenen T, Groseth A, van Doremalen N, Zemtsova G, Self J, Bushmaker T, McNally K, Rowe T, Emery SL, Feldmann F, Williamson B, Nyenswah TG, Grolla A, Strong JE, Kobinger G, Stroeher U, Rayfield M, Bolay FK, Zoon KC, Stassijns J, Tampellini L, de Smet M, Nichol ST, Fields B, Sprecher A, Feldmann H, Massaquoi M, Munster VJ.

Emerg Infect Dis. 2016 Feb;22(2):323-6. doi: 10.3201/eid2202.151656.

14.

Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool.

Hoenen T, Groseth A, Rosenke K, Fischer RJ, Hoenen A, Judson SD, Martellaro C, Falzarano D, Marzi A, Squires RB, Wollenberg KR, de Wit E, Prescott J, Safronetz D, van Doremalen N, Bushmaker T, Feldmann F, McNally K, Bolay FK, Fields B, Sealy T, Rayfield M, Nichol ST, Zoon KC, Massaquoi M, Munster VJ, Feldmann H.

Emerg Infect Dis. 2016 Feb;22(2):331-4. doi: 10.3201/eid2202.151796.

15.

Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine.

DeBuysscher BL, Scott D, Thomas T, Feldmann H, Prescott J.

NPJ Vaccines. 2016;1. pii: 16002. doi: 10.1038/npjvaccines.2016.2. Epub 2016 Jul 28.

16.

Humanized Mice--A Neoteric Animal Disease Model for Ebola Virus?

Prescott J, Feldmann H.

J Infect Dis. 2016 Mar 1;213(5):691-3. doi: 10.1093/infdis/jiv539. Epub 2015 Nov 17. No abstract available.

17.

Shedding of Ebola Virus in an Asymptomatic Pregnant Woman.

Akerlund E, Prescott J, Tampellini L.

N Engl J Med. 2015 Jun 18;372(25):2467-9. doi: 10.1056/NEJMc1503275. No abstract available.

18.

Ebola Virus Stability on Surfaces and in Fluids in Simulated Outbreak Environments.

Fischer R, Judson S, Miazgowicz K, Bushmaker T, Prescott J, Munster VJ.

Emerg Infect Dis. 2015 Jul;21(7):1243-6. doi: 10.3201/eid2107.150253.

19.

Lack of protection against ebola virus from chloroquine in mice and hamsters.

Falzarano D, Safronetz D, Prescott J, Marzi A, Feldmann F, Feldmann H.

Emerg Infect Dis. 2015 Jun;21(6):1065-7. doi: 10.3201/eid2106.150176.

20.

Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody Responses.

Prescott J, Falzarano D, Feldmann H.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S271-6. doi: 10.1093/infdis/jiv203. Epub 2015 May 5.

Supplemental Content

Loading ...
Support Center